These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27644192)

  • 21. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
    Summerfield NJ; Boswood A; O'Grady MR; Gordon SG; Dukes-McEwan J; Oyama MA; Smith S; Patteson M; French AT; Culshaw GJ; Braz-Ruivo L; Estrada A; O'Sullivan ML; Loureiro J; Willis R; Watson P
    J Vet Intern Med; 2012; 26(6):1337-49. PubMed ID: 23078651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
    Reina-Doreste Y; Stern JA; Keene BW; Tou SP; Atkins CE; DeFrancesco TC; Ames MK; Hodge TE; Meurs KM
    J Am Vet Med Assoc; 2014 Sep; 245(5):534-9. PubMed ID: 25148095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL; Leech E
    J Vet Emerg Crit Care (San Antonio); 2012 Aug; 22(4):398-408. PubMed ID: 22928748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW; Jöns O; Bussadori CM
    J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease.
    Boswood A; Smith S; Patteson M
    Vet Rec; 2011 Feb; 168(8):222. PubMed ID: 21493561
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of temperature variation on hospital admissions and outcomes in dogs with myxomatous mitral valve disease and new onset pulmonary edema.
    Guglielmini C; Toaldo MB; Chiesa A; Contiero B; Berlanda M; Poser H
    PLoS One; 2020; 15(1):e0227807. PubMed ID: 31935277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
    Yata M; Kooistra HS; Beijerink NJ
    J Vet Intern Med; 2019 Mar; 33(2):462-470. PubMed ID: 30703246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current use of pimobendan in canine patients with heart disease.
    Boswood A
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):571-80. PubMed ID: 20610012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A QUEST begins.
    Oyama MA
    J Vet Intern Med; 2008; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract]   [Full Text] [Related]  

  • 30. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
    Boswood A; Gordon SG; Häggström J; Vanselow M; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
    J Vet Intern Med; 2020 May; 34(3):1108-1118. PubMed ID: 32200574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.
    Fuentes VL; Corcoran B; French A; Schober KE; Kleemann R; Justus C
    J Vet Intern Med; 2002; 16(3):255-61. PubMed ID: 12041654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC; Fox PR
    J Vet Intern Med; 2016; 30(2):553-9. PubMed ID: 26936799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
    Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
    J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
    J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N; Kuse H; Kawasaki M; Hara A; Kano R; Sasaki Y
    J Vet Med Sci; 2007 Apr; 69(4):373-7. PubMed ID: 17485924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation.
    Suzuki S; Fukushima R; Ishikawa T; Hamabe L; Aytemiz D; Huai-Che H; Nakao S; Machida N; Tanaka R
    J Vet Intern Med; 2011; 25(6):1328-33. PubMed ID: 22092624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.
    Matson H; Llewellyn EA
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):231-237. PubMed ID: 38809224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of conventional and tissue Doppler echocardiography to predict congestive heart failure in dogs with myxomatous mitral valve disease.
    Kim JH; Park HM
    J Vet Intern Med; 2015 Jan; 29(1):132-40. PubMed ID: 25270196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compounded pimobendan for canine chronic degenerative mitral valve disease and pulmonary hypertension.
    Helms SR; Fox S; Mixon W; Vail J
    Int J Pharm Compd; 2012; 16(1):34-41. PubMed ID: 23050309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.